There are 2949 resources available
Q&A and live discussion
Presenter: Daniel Peeper
Session: Proffered Paper - Basic Science
Resources:
Webcast
Invited Discussant 700O and 701O
Presenter: Walter Berger
Session: Proffered Paper - GU, non prostate 2
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Manuela Schmidinger
Session: Proffered Paper - GU, non prostate 2
Resources:
Webcast
Invited Discussant 702O and LBA25
Presenter: Laurence Albiges
Session: Proffered Paper - GU, non prostate 2
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Manuela Schmidinger
Session: Proffered Paper - GU, non prostate 2
Resources:
Webcast
Invited Discussant LBA31 and 805O
Presenter: Isabelle Ray-Coquard
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Isabelle Ray-Coquard
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Webcast
Invited Discussant LBA32 and 807O
Presenter: Ana Oaknin
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Slides
Webcast
LBA31 - Primary results from IMagyn050/GOG 3015/ENGOT-OV39, a double-blind placebo (pbo)-controlled randomised phase III trial of bevacizumab (bev)-containing therapy +/- atezolizumab (atezo) for newly diagnosed stage III/IV ovarian cancer (OC)
Presenter: Kathleen Moore
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Abstract
Slides
Webcast
805O - ICON8: Overall survival results in a GCIG phase III randomised controlled trial of weekly dose-dense chemotherapy in first line epithelial ovarian, fallopian tube or primary peritoneal carcinoma treatment
Presenter: Andrew Clamp
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Abstract
Slides
Webcast